SE430185B - Med karboanhydras merkt trijodtyronin som medel for bestemning av trijodtyronin - Google Patents
Med karboanhydras merkt trijodtyronin som medel for bestemning av trijodtyroninInfo
- Publication number
- SE430185B SE430185B SE7802948A SE7802948A SE430185B SE 430185 B SE430185 B SE 430185B SE 7802948 A SE7802948 A SE 7802948A SE 7802948 A SE7802948 A SE 7802948A SE 430185 B SE430185 B SE 430185B
- Authority
- SE
- Sweden
- Prior art keywords
- tryodytyrinine
- determination
- enzyme
- activity
- antibody
- Prior art date
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 title 1
- 230000000694 effects Effects 0.000 claims description 14
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims description 7
- 230000001900 immune effect Effects 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- 238000000034 method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000007562 Serum Albumin Human genes 0.000 description 7
- 108010071390 Serum Albumin Proteins 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 102000009488 Thyroxine-Binding Proteins Human genes 0.000 description 6
- 108010048889 Thyroxine-Binding Proteins Proteins 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 229940035722 triiodothyronine Drugs 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 102000002248 Thyroxine-Binding Globulin Human genes 0.000 description 3
- 108010000259 Thyroxine-Binding Globulin Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 3
- YBADLXQNJCMBKR-UHFFFAOYSA-M (4-nitrophenyl)acetate Chemical compound [O-]C(=O)CC1=CC=C([N+]([O-])=O)C=C1 YBADLXQNJCMBKR-UHFFFAOYSA-M 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 108091011044 hormone binding proteins Proteins 0.000 description 2
- 102000036124 hormone binding proteins Human genes 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- AUYYCJSJGJYCDS-UHFFFAOYSA-N 2/3/6893 Natural products IC1=CC(CC(N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-UHFFFAOYSA-N 0.000 description 1
- -1 3-dimethylaminopropyl Chemical group 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 102000007584 Prealbumin Human genes 0.000 description 1
- 108010071690 Prealbumin Proteins 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102100029290 Transthyretin Human genes 0.000 description 1
- 108050000089 Transthyretin Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21231/77A IT1153999B (it) | 1977-03-15 | 1977-03-15 | Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7802948L SE7802948L (sv) | 1978-09-16 |
| SE430185B true SE430185B (sv) | 1983-10-24 |
Family
ID=11178747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7802948A SE430185B (sv) | 1977-03-15 | 1978-03-14 | Med karboanhydras merkt trijodtyronin som medel for bestemning av trijodtyronin |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4250253A (da) |
| JP (1) | JPS53115813A (da) |
| AU (1) | AU515842B2 (da) |
| BE (1) | BE864934A (da) |
| CA (1) | CA1100869A (da) |
| CH (1) | CH636450A5 (da) |
| CS (1) | CS217962B2 (da) |
| DD (1) | DD138246A5 (da) |
| DE (1) | DE2811057C2 (da) |
| DK (1) | DK149909C (da) |
| FR (1) | FR2384259A1 (da) |
| GB (1) | GB1575267A (da) |
| HU (1) | HU182037B (da) |
| IL (1) | IL54184A0 (da) |
| IT (1) | IT1153999B (da) |
| LU (1) | LU79219A1 (da) |
| NL (1) | NL177627C (da) |
| NO (1) | NO150813C (da) |
| SE (1) | SE430185B (da) |
| SU (1) | SU1158029A3 (da) |
| YU (1) | YU41429B (da) |
| ZA (1) | ZA781364B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4292296A (en) * | 1978-09-12 | 1981-09-29 | Baxter Travenol Laboratories, Inc. | Diagnostic method |
| JPS6385358A (ja) * | 1986-09-29 | 1988-04-15 | Eiken Kagaku Kk | 血中遊離型トリヨ−ドサイロニンの酵素免疫測定法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1602865A (da) * | 1964-07-16 | 1971-02-08 | ||
| NL154600B (nl) * | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| USRE29163E (en) * | 1969-03-03 | 1977-03-29 | Hoffmann-La Roche Inc. | 1,2,3,4,10,19-Hexanor-9-oxo-5,9-seco-25D-spirostan-5-oic acid |
| NL154598B (nl) * | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| NL171930C (nl) * | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US4040907A (en) * | 1974-06-20 | 1977-08-09 | Syva Company | Iodothyronine enzyme conjugates |
| CA1028643A (en) * | 1975-02-20 | 1978-03-28 | Judith I. Blakemore | Polylodothyronine immunoassay |
| NL7505699A (nl) * | 1975-05-15 | 1976-11-17 | Philips Nv | Wormoverbrenging. |
| JPS5272284A (en) * | 1975-12-12 | 1977-06-16 | Dainippon Pharmaceutical Co | Enzymeeimmunoassay reagent |
-
1977
- 1977-03-15 IT IT21231/77A patent/IT1153999B/it active
-
1978
- 1978-03-01 AU AU33703/78A patent/AU515842B2/en not_active Expired
- 1978-03-03 IL IL54184A patent/IL54184A0/xx not_active IP Right Cessation
- 1978-03-08 ZA ZA00781364A patent/ZA781364B/xx unknown
- 1978-03-09 US US05/884,811 patent/US4250253A/en not_active Expired - Lifetime
- 1978-03-09 GB GB9458/78A patent/GB1575267A/en not_active Expired
- 1978-03-13 DD DD78204143A patent/DD138246A5/xx unknown
- 1978-03-13 NO NO780881A patent/NO150813C/no unknown
- 1978-03-13 LU LU79219A patent/LU79219A1/xx unknown
- 1978-03-13 FR FR7807195A patent/FR2384259A1/fr active Granted
- 1978-03-13 YU YU592/78A patent/YU41429B/xx unknown
- 1978-03-14 HU HU78SA3099A patent/HU182037B/hu not_active IP Right Cessation
- 1978-03-14 CA CA298,913A patent/CA1100869A/en not_active Expired
- 1978-03-14 DE DE2811057A patent/DE2811057C2/de not_active Expired
- 1978-03-14 CH CH277578A patent/CH636450A5/it not_active IP Right Cessation
- 1978-03-14 DK DK113278A patent/DK149909C/da not_active IP Right Cessation
- 1978-03-14 SE SE7802948A patent/SE430185B/sv not_active IP Right Cessation
- 1978-03-14 CS CS781613A patent/CS217962B2/cs unknown
- 1978-03-15 SU SU782589948A patent/SU1158029A3/ru active
- 1978-03-15 BE BE185967A patent/BE864934A/xx not_active IP Right Cessation
- 1978-03-15 NL NLAANVRAGE7802820,A patent/NL177627C/xx not_active IP Right Cessation
- 1978-03-15 JP JP2878078A patent/JPS53115813A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT1153999B (it) | 1987-01-21 |
| YU41429B (en) | 1987-06-30 |
| JPS6161064B2 (da) | 1986-12-24 |
| CA1100869A (en) | 1981-05-12 |
| SU1158029A3 (ru) | 1985-05-23 |
| HU182037B (en) | 1983-12-28 |
| JPS53115813A (en) | 1978-10-09 |
| SE7802948L (sv) | 1978-09-16 |
| DE2811057C2 (de) | 1982-07-29 |
| YU59278A (en) | 1985-04-30 |
| LU79219A1 (fr) | 1978-06-28 |
| US4250253A (en) | 1981-02-10 |
| FR2384259A1 (fr) | 1978-10-13 |
| NO150813C (no) | 1985-01-02 |
| IL54184A0 (en) | 1978-06-15 |
| BE864934A (fr) | 1978-09-15 |
| DD138246A5 (de) | 1979-10-17 |
| AU3370378A (en) | 1979-09-06 |
| DE2811057A1 (de) | 1978-09-21 |
| ZA781364B (en) | 1979-03-28 |
| CH636450A5 (it) | 1983-05-31 |
| DK113278A (da) | 1978-09-16 |
| NL177627C (nl) | 1985-10-16 |
| FR2384259B1 (da) | 1981-09-11 |
| NO150813B (no) | 1984-09-10 |
| AU515842B2 (en) | 1981-05-07 |
| DK149909B (da) | 1986-10-20 |
| DK149909C (da) | 1987-03-09 |
| CS217962B2 (en) | 1983-02-25 |
| NO780881L (no) | 1978-09-18 |
| NL7802820A (nl) | 1978-09-19 |
| GB1575267A (en) | 1980-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1195925A (en) | Method for assaying antigen-antibody reactions and reagent therefor | |
| SE443660B (sv) | Forfarande och reagens for immunanalys med rf eller clq adsorberat till fast berare | |
| CN101833009A (zh) | 一种双抗体复合的视黄醇结合蛋白检测试剂盒 | |
| CN102841206A (zh) | 肌钙蛋白T(Troponin-T,TNT)测定试剂盒 | |
| Nilsson et al. | Automated immunochemical binding assay (flow-ELISA) based on repeated use of an antibody column placed in a flow-injection system | |
| CN110133270A (zh) | 一种增强免疫抑制比浊抗体筛选试剂及其制作和使用方法 | |
| EP0064275B1 (en) | Immunochemical reagent | |
| SE430185B (sv) | Med karboanhydras merkt trijodtyronin som medel for bestemning av trijodtyronin | |
| JPH08304406A (ja) | カリブレーターマトリックス | |
| CA1162846A (en) | Hemolytic method for the continuous determination of antistreptolysin o antibodies in blood or serum samples, using oxidised streptolysin o | |
| JPS6243501B2 (da) | ||
| JPH026023B2 (da) | ||
| JPH02257063A (ja) | 免疫測定試薬および免疫測定法 | |
| JPH03272698A (ja) | 遊離ヘモグロビンの測定法及びそれに用いる遊離ヘモグロビン測定用試薬キット | |
| JPH0694716A (ja) | 免疫測定法 | |
| JPH05203579A (ja) | 被分析物の濁度分析または比朧分析のための方法および試薬 | |
| JPH04203967A (ja) | 微量成分の迅速測定方法 | |
| GB1600139A (en) | Method and apparatus for the measurement of antigens and antibodies | |
| JP3423085B2 (ja) | 免疫測定法 | |
| JPH08193999A (ja) | 免疫測定法 | |
| JPH1144688A (ja) | 蛍光偏光免疫測定法 | |
| JP2001228153A (ja) | 免疫学的測定方法 | |
| JPH0456258B2 (da) | ||
| JP3481015B2 (ja) | 免疫比濁測定法 | |
| JPS63222257A (ja) | 多抗原同時測定用免疫センサ− |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7802948-5 Effective date: 19941010 Format of ref document f/p: F |